HomeQuestion
Would you offer neoadjuvant pembrolizumab to a TNBC patient with multiple pulmonary nodules and bilateral hilar adenopathy secondary to asymptomatic sarcoidosis (biopsy proven)?
2 Answers
Mednet Member
Medical Oncology · Warren Alpert Medical School of Brown University
Given the potential benefits of the addition of pembrolizumab to neoadjuvant chemotherapy in clinical stage IIB-III TNBC, I would favor doing so [but not for clinical stage I or small IIA (T<3 cm N0), in whom the potential benefits would be more modest], but I would monitor the patient closely for a...